Observational studyDigestion2021

Leucine-Rich Alpha-2 Glycoprotein May Be Predictive of the Adalimumab Trough Level and Antidrug Antibody Development for Patients with Inflammatory Bowel Disease: A Sub-Analysis of the PLANET Study.

Shunichi Yanai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.